CL2016003010A1 - Sistema de expresión optogenético en levadura - Google Patents

Sistema de expresión optogenético en levadura

Info

Publication number
CL2016003010A1
CL2016003010A1 CL2016003010A CL2016003010A CL2016003010A1 CL 2016003010 A1 CL2016003010 A1 CL 2016003010A1 CL 2016003010 A CL2016003010 A CL 2016003010A CL 2016003010 A CL2016003010 A CL 2016003010A CL 2016003010 A1 CL2016003010 A1 CL 2016003010A1
Authority
CL
Chile
Prior art keywords
optogenetic
expression system
yeast
transcription
gene
Prior art date
Application number
CL2016003010A
Other languages
English (en)
Inventor
Fernando Larrondo Castro Luis
Esteban Agosin Trumper Eduardo
José Salinas Sanhueza Francisco
Alberto Rojas Jorquera Vicente
Melissa Delgado Hernández Verónica
Original Assignee
Univ Pontificia Catolica Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pontificia Catolica Chile filed Critical Univ Pontificia Catolica Chile
Priority to CL2016003010A priority Critical patent/CL2016003010A1/es
Priority to PCT/CL2017/050066 priority patent/WO2018094542A1/es
Publication of CL2016003010A1 publication Critical patent/CL2016003010A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención corresponde a un sistema de expresión optogenético en levadura y un método para regular la expresión de un gen en una célula hospedera, donde el sistema de expresión optogenético comprende al menos dos fotorreceptores, o proteínas sensibles a luz distintas que pueden formar un factor de transcripción quimérico, donde una vez que el sistema se expone a la luz, se genera un cambio conformacional que permite la dimerización entre ambos fotorreceptores distintos, formándose así el factor de transcripción, permitiendo la unión de dicho factor de transcripción al promotor, generando así la transcripción del gen de interés. 
CL2016003010A 2016-11-24 2016-11-24 Sistema de expresión optogenético en levadura CL2016003010A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2016003010A CL2016003010A1 (es) 2016-11-24 2016-11-24 Sistema de expresión optogenético en levadura
PCT/CL2017/050066 WO2018094542A1 (es) 2016-11-24 2017-11-15 Sistema de expresión optogenético en levadura

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2016003010A CL2016003010A1 (es) 2016-11-24 2016-11-24 Sistema de expresión optogenético en levadura

Publications (1)

Publication Number Publication Date
CL2016003010A1 true CL2016003010A1 (es) 2018-11-09

Family

ID=62194645

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016003010A CL2016003010A1 (es) 2016-11-24 2016-11-24 Sistema de expresión optogenético en levadura

Country Status (2)

Country Link
CL (1) CL2016003010A1 (es)
WO (1) WO2018094542A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102643852B (zh) * 2011-02-28 2015-04-08 华东理工大学 光可控的基因表达系统
US20160326219A1 (en) * 2013-12-13 2016-11-10 Ist Austria (Institute Of Science And Technology Austria) Optically activated receptors

Also Published As

Publication number Publication date
WO2018094542A1 (es) 2018-05-31

Similar Documents

Publication Publication Date Title
CY1122909T1 (el) Μεθοδοι αντιμετωπισης της ηωσινοφιλικης οισοφαγιτιδας με χορηγηση αναστολεα του ιl-4r
CY1122833T1 (el) Ογκολυτικος αδενοϊος που κωδικοποιει μια πρωτεϊνη β7
CY1123932T1 (el) Δομες πολυειδικου αντισωματος
BR112017006736A2 (pt) anticorpos antimiostatina, polipeptídeos contendo regiões fc variantes, e métodos de utilização
CY1124845T1 (el) Μεθοδοι παροχης μονοκλωνου rna
ECSP18062614A (es) Moléculas que activan selectivamente las células t reguladoras para el tratamiento de enfermedades autoinmunes
CY1123957T1 (el) Θεραπεια συνδυασμου για καρκινο
CY1121359T1 (el) Ενωσεις ετεροαρυλιου για αναστολη κινασης
BR112018073628A2 (pt) anticorpos antimiostatina e métodos de utilização
CY1123282T1 (el) Μεθοδοι και συσκευες για απτικα συστηματα
CL2016001507A1 (es) Compuestos para tratar pacientes con células cancerosas mutantes ros1
CL2018003136A1 (es) Proteínas de unión específica y usos de las mismas.
BR112018074463A2 (pt) anticorpos anti-tim-3 e métodos de uso dos mesmos.
BR112019001737A2 (pt) expressão de pten-long com vírus oncolíticos
SV2018005781A (es) Proteinas de fusión gdf15 y usos de éstas
BR112018013074A2 (pt) terapias de célula efetora imune com eficácia real-çada
ECSP20081591A (es) Proteínas de fusión que comprenden progranulina
BR112018073861A2 (pt) métodos de terapia de genes para doenças e condições relacionadas com a idade
CY1123093T1 (el) Φαρμακοφορο για την επαγωγη του trail
MX2018008346A (es) Terapia de combinación de virus oncológico e inhibidor de punto de control.
BR112017008490A2 (pt) colchão para fornecer fototerapia a um indivíduo, método para fornecer fototerapia a um indivíduo com um colchão para fototerapia, e sistema de colchão para fornecer fototerapia a um indivíduo
BR112016027222A2 (pt) anticorpos isolados, ácido nucleico isolado, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, métodos de tratamento de um indivíduo com um câncer, de inibição da proliferação de uma célula, de detecção de gpc3 humano e de detecção de um câncer
CY1122214T1 (el) Αντισωματα ειδικα για ton fcrn
BR112017023131A2 (pt) anticorpos anti- fcrn
BR112014029346A2 (pt) sistema e método implementado por computador para a montagem de um plano de tratamento médico